Skip to main content
Professional Technical IVT

spinal muscular atrophy

Genetic neuromuscular disorder caused by motor neuron degeneration, leading to progressive muscle weakness and atrophy.

Full Definition

Spinal muscular atrophy (SMA) is a group of hereditary neuromuscular disorders characterized by degeneration of motor neurons in the spinal cord anterior horn, resulting in progressive muscle weakness and atrophy. The most common form is caused by homozygous deletion or mutation of the survival motor neuron 1 (SMN1) gene. SMA is classified into types 0-4 based on age of onset and maximum motor function achieved, with Type I (Werdnig-Hoffmann disease) being the most severe infantile form. Clinical features include floppy infant syndrome, delayed motor milestones, and respiratory complications. Recent therapeutic advances include antisense oligonucleotides, gene therapy, and SMN2 splice modulators, significantly improving outcomes especially when treatment begins early.

Usage

Usage note: SMA abbreviation widely accepted; specify type when relevant (e.g., SMA Type I).

In Context

  • "Genetic testing confirmed spinal muscular atrophy type II with homozygous SMN1 gene deletion." — Genetic counseling report
  • "Early treatment with nusinersen improved motor outcomes in this infant with spinal muscular atrophy." — Clinical case report

Also known as

SMA

Don't confuse with

muscular dystrophy congenital myopathy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON